NYSE:DOCS Doximity Q2 2025 Earnings Results & Report $30.49 -0.09 (-0.28%) Closing price 03:59 PM EasternExtended Trading$30.42 -0.07 (-0.24%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Doximity missed analyst earnings expectations but beat on revenue in its Q2 2025 results, released November 7, 2024. The company reported EPS of $0.24 versus the $0.2560 consensus estimate, while revenue of $136.83 million topped the $127.05 million estimate by $9.78 million. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ2 2025Report DateNovember 7, 2024TimeAfter Market Closes Doximity EPS ResultsActual EPS$0.24Consensus EPS $0.2560Beat/MissMissed by -$0.0160One Year Ago EPS$0.18EPS Beat Rate7 of last 8 quartersDoximity Revenue ResultsActual Revenue$136.83 millionExpected Revenue$127.05 millionBeat/MissBeat by +$9.78 millionYoY Revenue GrowthN/AConference Call ResourcesEarnings HistoryCompany Profile Doximity Q2 2025 Earnings FAQ Did Doximity beat earnings estimates for Q2 2025? Doximity (NYSE:DOCS) reported earnings of $0.24 per share for Q2 2025, missing the consensus estimate of $0.2560. The report was announced on Thursday, November 7, 2024. What was Doximity's revenue for Q2 2025? Doximity reported revenue of $136.83 million for Q2 2025, against a consensus estimate of $127.05 million. Doximity Earnings HeadlinesDoximity, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - DOCS1 hour ago | prnewswire.comDoximity Extends Partnership With US News & World Report4 hours ago | finance.yahoo.comBuffett's Final Warning: "The Dollar Is Going to Hell"On May 3rd, 2025, Warren Buffett looked at his shareholders for the last time and said: "The dollar is going to hell." Ray Dalio agrees. The founder of Bridgewater Associates ($150 billion AUM) calls it a "debt death spiral." But there's a specific asset class and investment system that actually thrives when the dollar collapses.October 13 at 1:00 AM | Decentralized Masters (Ad)INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Doximity, Inc. of Class Action Lawsuit and Upcoming Deadlines – DOCSOctober 13 at 5:29 PM | globenewswire.comROSEN, REGARDED INVESTOR COUNSEL, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DOCSOctober 13 at 4:11 PM | globenewswire.comDOCS Shareholder Alert: Doximity, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact SueWallStOctober 13 at 2:34 PM | globenewswire.comSee More Doximity Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Doximity? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Doximity and other key companies, straight to your email. Email Address About DoximityDoximity (NYSE:DOCS) operates a digital platform designed for U.S. medical professionals. Its network enables physicians, nurse practitioners, physician assistants and other healthcare providers to connect with colleagues, exchange clinical information and access professional resources. The company offers tools for telehealth and care coordination, including video and phone-based communication services, as well as digital faxing and secure messaging capabilities. Doximity also provides medical news and research content tailored to healthcare professionals. Doximity generates additional business through recruiting and marketing solutions that help healthcare organizations reach clinicians and promote employment opportunities, services and products. Its platform is primarily focused on the United States healthcare market. Founded in 2010, Doximity was co-founded by Jeff Tangney, Nate Gross and Shari Buck. Jeff Tangney serves as the company's chief executive officer, and Doximity became publicly traded on the New York Stock Exchange under the symbol DOCS in 2021.View Doximity ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles A Chinese Rival Just Spooked Memory Stocks—How Worried Should Micron Investors Be?Surgical Precision, Sustainable Returns: Johnson & Johnson Secures Its Cash Flow RunwayJPMorgan Earnings Miss Estimates But Reveal Broad-Based StrengthAmazon's $220 Billion AI Bet Is Getting Bigger—Can Earnings Justify the Spending?A Silent Winner: Texas Instruments Anchors the AI SupercycleDelta's Guidance Cut Could Spell Trouble for the Airline Industry5 Retail Picks to Watch as the Holiday Shopping Season Nears Upcoming Earnings Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026)Progressive (10/14/2026)Fastenal (10/14/2026)ASML (10/14/2026)Interactive Brokers Group (10/15/2026)Marsh & McLennan Companies (10/15/2026)The PNC Financial Services Group (10/15/2026)Charles Schwab (10/15/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.